drugset / Trial / NCT00926393

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

NCT00926393

Phase 4 Completed 139 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blind

Summary

The purpose of the study is to compare the sedation profile one hour after dose administration between Seroquel IR and Seroquel XR.

Timeline

Start
2009-06
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 25 mg Oral
Comparator Quetiapine Small molecule 50 mg Oral
Comparator Quetiapine Small molecule 100 mg Oral
Comparator Quetiapine Small molecule 200 mg Oral
Comparator Quetiapine Small molecule 300 mg Oral

Indications